Find a Tender
complete
Official procurement procedure
NHS North of England Branded Medicines Tranche A & Annual Tranche
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS North of England Branded Medicines Tranche A & Annual Tranche". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
46.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published15 Mar 2023, 10:39 GMT | Last source update15 Mar 2023, 10:39 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-036b0f | ||
What is being bought
NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.<br/>Offer reference number: CM/PHR/20/5606<br/>CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months<br/>CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months
What changed
From the official release history
- tender value changed
15 Mar 2023, 10:39 GMT - Status changed to complete
15 Mar 2023, 10:39 GMT - Official notice release published
15 Mar 2023, 10:39 GMT - Submission deadline changed to published date
15 Mar 2023, 10:39 GMT - Published value updated to £653,653,647
23 Sept 2022, 15:06 BST - Status changed to active
23 Sept 2022, 15:06 BST - Official notice release published
23 Sept 2022, 15:06 BST - Submission deadline changed to 24 Oct 2022, 13:00 BST
23 Sept 2022, 15:06 BST - Buyer information updated
23 Sept 2022, 15:06 BST
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1CM/PHR/20/5606/01 - NHS Framework for North of England Branded - Tranche AcancelledPublished valueNot publishedLot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2CM/PHR/20/5606/02 - NHS Framework for North of England Branded - Annual TranchecancelledPublished valueNot publishedCM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3CM/PHR/20/5606/03 - NHS Supply of Risankizumab for South of England & LondoncancelledPublished valueNot publishedLot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
15 Mar 2023, 10:39 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1 - Contract active
Signed 14 Mar 2023, 00:00 GMT · £1
Commercial outcome and competition
Awards Roche Products Ltd Not published · Not published · active Ipsen Not published · Not published · active Pharmacosmos UK Ltd Not published · Not published · active Merck Serono Limited Not published · Not published · active Novo Nordisk Not published · Not published · active Merz Not published · Not published · active Vifor Pharma UK Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active Celltrion Healthcare United Kingdom Limited Not published · Not published · active Merck Sharpe and Dohme (UK) Limited Not published · Not published · active Sandoz Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active GlaxoSmithKline UK Limited Not published · Not published · active Abbvie Ltd Not published · Not published · active Aventis Pharma ltd t/a Sanofi Not published · Not published · active AstraZeneca Not published · Not published · active Takeda UK Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active Organon Pharmaceuticals UK Ltd Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active Sobi (Swedish Orphan Biovitrum Ltd) Not published · Not published · active Gedeon Richter UK Ltd Not published · Not published · active Almirall Not published · Not published · active UCB Pharma Ltd (primary) Not published · Not published · active Abbvie Ltd Not published · Not published · active Chugai Pharma UK Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Abbvie Ltd Not published · Not published · active |
Contracts Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A £1 · signed 14 Mar 2023, 00:00 GMT · active |
Bid statistics bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) bids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) electronicBids: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromEU: 15 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-3022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published